C

Canbridge Pharmaceuticals Inc
HKEX:1228

Watchlist Manager
Canbridge Pharmaceuticals Inc
HKEX:1228
Watchlist
Price: 2.26 HKD -2.59% Market Closed
Market Cap: 1.2B HKD

Wall Street
Price Targets

Price Targets Summary
Canbridge Pharmaceuticals Inc

There are no price targets for Canbridge Pharmaceuticals Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Canbridge Pharmaceuticals Inc Competitors:
Price Targets
VITR
Vitrolife AB
40% Upside
VCEL
Vericel Corp
39% Upside
CSL
CSL Ltd
40% Upside
ASMB
Assembly Biosciences Inc
55% Upside
SCLP
Scancell Holdings PLC
216% Upside
DAWN
Day One Biopharmaceuticals Inc
136% Upside
BMEA
Biomea Fusion Inc
437% Upside
BNTX
BioNTech SE
39% Upside

Revenue
Forecast

Revenue Estimate
Canbridge Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Canbridge Pharmaceuticals Inc's revenue is 4%. The projected CAGR for the next 2 years is 90%.

4%
Past Growth
90%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Canbridge Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
35%
Average Beat

Net Income
Forecast

Net Income Estimate
Canbridge Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Canbridge Pharmaceuticals Inc's stock price target?
Not Available

Canbridge Pharmaceuticals Inc doesn't have any price targets made by Wall Street professionals.

What is Canbridge Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
90%

For the last 13 years the compound annual growth rate for Canbridge Pharmaceuticals Inc's revenue is 4%. The projected CAGR for the next 2 years is 90%.

Back to Top